Asthma - Pipeline Review, H1 2014

www.MarketResearchReports.com

Asthma - Pipeline

Review, H1 2014

Category : Pharma & Healthcare

All logos and Images mentioned on this slide belong to their respective owners.

http://www.marketresearchreports.com/


Introduction to Report

Launch Date: April 30, 2014

Number of Pages: 686

Geography Coverage: Global

Available Format: PDF

Price For Single User License: USD 2,500

Price For Site User License: USD 5,000

Price For Global User License: USD 7,500

Delivery Time: Within 24 Hours (During Working Days)



About the Report

This report provides comprehensive information on the therapeutic development for Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

It also reviews key players involved in the therapeutic development for Asthma and special features on late-stage and discontinued projects.



Research Findings

The report is built using data and information sourced from Publisher’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Publisher’s team.

Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.

Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.



Scope

The report provides a snapshot of the global therapeutic landscape of Asthma

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Asthma and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects



Scope Continues…

A review of the Asthma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Asthma pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products



Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Asthma

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Asthma pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline



Report Coverage

1. Introduction2. Asthma Overview3. Therapeutics Developmen4. Drug Profiles5. Appendix

For more details regarding Report coverage see the last slide




Company Coverage (Partial List)

1. Alcon, Inc.2. Johnson & Johnson3. Boehringer Ingelheim GmbH4. F. Hoffmann-La Roche Ltd.5. Kyowa Hakko Kirin Co., Ltd.6. Amgen Inc.7. AstraZeneca PLC8. GlaxoSmithKline plc9. Genentech, Inc.10. Biotec Pharmacon ASA11. MedImmune, LLC12. Daiichi Sankyo Company13. Limited Merck & Co., Inc.14. Nissan Chemical Industries, Ltd.

For more details regarding Report coverage see the last slide




Custom Research: Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

http://www.marketresearchreports.com/idea-center



How To Buy This Report?

Visit following URL to see Table of Content and purchase this publication:

http://mrr.cm/ZG6

About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.

Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)

http://mrr.cm/ZG6

http://mrr.cm/ZG6

mailto:[email protected]


Asthma - Pipeline Review, H1 2014

Healthcare

Transcript of Asthma - Pipeline Review, H1 2014